Human Health Antimicrobial Resistance Surveillance in New Zealand: The Current State and Future Direction.

IF 2.1
Journal of the Royal Society of New Zealand Pub Date : 2026-10-14 eCollection Date: 2026-10-01 DOI:10.1002/snz2.70086
Julianna Lees, Andrea McNeill, Kristin Dyet, Sarah Bakker, Juliet Elvy, Mandy Sexton, Hilary Miller, Jing Wang, David Winter, Jackie Wright, Ernest Williams, Shevaun Paine, Elena Cremm, Meghna Ramchandani, Isabelle Pattis, Zuyu Yang, Rhys White, David Murdoch
{"title":"Human Health Antimicrobial Resistance Surveillance in New Zealand: The Current State and Future Direction.","authors":"Julianna Lees, Andrea McNeill, Kristin Dyet, Sarah Bakker, Juliet Elvy, Mandy Sexton, Hilary Miller, Jing Wang, David Winter, Jackie Wright, Ernest Williams, Shevaun Paine, Elena Cremm, Meghna Ramchandani, Isabelle Pattis, Zuyu Yang, Rhys White, David Murdoch","doi":"10.1002/snz2.70086","DOIUrl":null,"url":null,"abstract":"<p><p>Human health antimicrobial resistance (AMR) surveillance in New Zealand has demonstrated substantial value in detecting, monitoring and responding to emerging threats. AMR is an escalating global problem and strengthening surveillance systems will be critical for ensuring New Zealand remains equipped to address this growing threat. This paper provides an overview of the current human health AMR surveillance system in New Zealand, describing its structure, data sources and key components. Using selected case studies, we demonstrate the value of integrated laboratory, epidemiological and genomic data in detecting emerging threats, monitoring trends and informing public health and clinical responses. We also highlight work underway to strengthen AMR surveillance in New Zealand including improvements to data standardisation, laboratory information systems and national coordination, alongside increasing engagement with international surveillance initiatives. Finally, we highlight the need to progress toward a more integrated AMR surveillance approach that incorporates human, animal and environmental surveillance to better respond to AMR.</p>","PeriodicalId":520341,"journal":{"name":"Journal of the Royal Society of New Zealand","volume":"56 5","pages":"e70086"},"PeriodicalIF":2.1000,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13667798/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Royal Society of New Zealand","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/snz2.70086","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Human health antimicrobial resistance (AMR) surveillance in New Zealand has demonstrated substantial value in detecting, monitoring and responding to emerging threats. AMR is an escalating global problem and strengthening surveillance systems will be critical for ensuring New Zealand remains equipped to address this growing threat. This paper provides an overview of the current human health AMR surveillance system in New Zealand, describing its structure, data sources and key components. Using selected case studies, we demonstrate the value of integrated laboratory, epidemiological and genomic data in detecting emerging threats, monitoring trends and informing public health and clinical responses. We also highlight work underway to strengthen AMR surveillance in New Zealand including improvements to data standardisation, laboratory information systems and national coordination, alongside increasing engagement with international surveillance initiatives. Finally, we highlight the need to progress toward a more integrated AMR surveillance approach that incorporates human, animal and environmental surveillance to better respond to AMR.

新西兰人类健康抗菌素耐药性监测:现状和未来方向。
新西兰对人类健康抗菌素耐药性(AMR)的监测在发现、监测和应对新出现的威胁方面显示出巨大价值。抗菌素耐药性是一个不断升级的全球问题,加强监测系统对于确保新西兰仍然有能力应对这一日益严重的威胁至关重要。本文概述了新西兰目前的人类健康抗菌素耐药性监测系统,描述了其结构、数据来源和关键组成部分。通过选定的案例研究,我们展示了综合实验室、流行病学和基因组数据在发现新出现的威胁、监测趋势以及为公共卫生和临床反应提供信息方面的价值。我们还强调了正在进行的加强新西兰抗菌素耐药性监测的工作,包括改进数据标准化、实验室信息系统和国家协调,同时加强与国际监测倡议的接触。最后,我们强调需要朝着更综合的抗菌素耐药性监测方法迈进,将人类、动物和环境监测结合起来,以更好地应对抗菌素耐药性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书